Levetiracetam
Product Images NDC 65977-5037

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 65977-5037). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hetero Drugs Ltd.,, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1000 mg (30s count)

Levetiracetam 1000 mg tablets packaging label from Hetero Drugs Ltd. The label indicates the product contains 30 tablets, is Rx only, and includes handling instructions for pharmacists and storage conditions at controlled room temperature. The label also features barcodes and the manufacturer's address in Hyderabad, India.*

FDA Label Image

250 mg (30s count)

Levetiracetam 250 mg tablets packaging label by Hetero Drugs Ltd. The label indicates 30 tablets per box, with a blue and red color scheme. Storage instructions mention storing below 30°C (86°F). The label includes a barcode and manufacturing details.*

FDA Label Image

500 mg (30s count)

Levetiracetam 500 mg tablets packaging label from Hetero Drugs Ltd. The label indicates each film-coated tablet contains 500 mg levetiracetam. The package includes 30 tablets and advises storage at 20° to 25°C (68° to 77°F). It includes warnings for pharmacist dispensing and medication guide requirements. The manufacturer location is Hyderabad, India.*

FDA Label Image

750 mg (30s count)

Levetiracetam Tablets 750 mg label from Hetero Drugs Ltd. The label specifies the strength as 750 mg and indicates the package contains 30 tablets. Instructions include dispensing in tight, light-resistant, and child-resistant containers, and storage at 20° to 25°C (68° to 77°F). The label states 'Rx only' and emphasizes that each patient must receive the accompanying Medication Guide.*

FDA Label Image

Address (Address.jpg)

Packaging label segment showing manufacturer information for Levetiracetam by Hetero Drugs Limited. Includes the company's address in Hyderabad, India, a logo, and a code with revision number. The word "Barcode" is printed but no barcode is visible.*

FDA Label Image

Figure 1 (Figure1.jpg)

Bar chart comparing the percentage of patients across three groups: Placebo (7.4%), Levetiracetam 1000 mg/day (37.1%), and Levetiracetam 3000 mg/day (39.6%). The y-axis shows percentage of patients, and the x-axis lists the treatment groups with their respective sample sizes.*

FDA Label Image

Figure 2 (Figure2.jpg)

A bar chart comparing the percentage of patients across three groups: placebo, Levetiracetam 1000 mg/day, and Levetiracetam 2000 mg/day. The vertical axis represents the percentage of patients from 0% to 45%. Placebo shows approximately 6.3%, Levetiracetam 1000 mg/day about 20.8%, and Levetiracetam 2000 mg/day around 35.2% patients.*

FDA Label Image

Figure 3 (Figure3.jpg)

A bar chart comparing the percentage of patients in two groups: Placebo (N=104) with 14.4% and Levetiracetam 3000 mg/day (N=180) with 39.4%. The vertical axis represents the percentage of patients from 0% to 45%.*

FDA Label Image

Figure 4 (Figure4.jpg)

A bar chart comparing the percentage of patients between groups receiving placebo and levetiracetam. The vertical axis represents the percentage of patients, with the placebo group at 19.6% and the levetiracetam group at 44.6%. Patient counts are indicated below the bars for placebo (N=97) and levetiracetam (N=101).*

FDA Label Image

Figure 5 (Figure5.jpg)

A bar chart comparing the percentage of patients between placebo and Levetiracetam treatment groups. The chart shows approximately 45.2% for placebo (N=84) and 72.2% for Levetiracetam (N=79). The y-axis represents percentage of patients from 0% to 100%.*

FDA Label Image

Structure (Structure.jpg)

Chemical structure of levetiracetam, showing its molecular arrangement including a pyrrolidone ring and other bonded groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.